<DOC>
	<DOCNO>NCT01824498</DOCNO>
	<brief_summary>The primary objective investigation determine whether diet design increase plasma n3 concentration ( low fat diet , without n3 fatty acid enrichment ) , favorably affect sex hormone distribution woman direction associate reduce risk sex hormone-mediated cancer development . Specifically , hypothesize increase concentration circulate n3 fatty acid reduce biochemical marker associate increase risk develop certain sex hormone mediate cancer breast cancer</brief_summary>
	<brief_title>Dietary Fat , Eicosanoids Breast Cancer Risk</brief_title>
	<detailed_description>The guiding concept proposal total fat fatty acid composition diet contribute milieu associate risk sex-hormone mediate cancer . Specifically , hypothesize increase concentration circulate n3 fatty acid reduce biochemical marker associate increase risk develop certain sex hormone mediate cancer breast cancer . When compare high fat diet , expect n3 concentration increase sex hormone level decrease low fat low fat/n3 rich diet , great response low fat-n3 supplement group . The aim project : 1 ) evaluate effect total fat n3 fatty acid consumption plasma urine sex hormone concentration postmenopausal woman , 2 ) evaluate relationship plasma concentration fatty acid plasma urinary sex hormone concentration , 3 ) evaluate effect total fat n3 fatty acid consumption association sex hormone concentration urinary prostaglandin E2 thromboxane B2 concentration . The primary objective investigation determine whether diet design increase plasma n3 concentration ( low fat diet , without n3 fatty acid enrichment ) , favorably affect sex hormone distribution woman direction associate reduce risk sex hormone-mediated cancer development . The primary endpoint evaluate include plasma urinary sex hormone concentration follow : Endpoints associate increase risk factor breast cancer risk : plasma estradiol ( E2 ) , estrone ( E1 ) , estrone sulfate ( E1 sulfate ) , testosterone , androstenedione , sex hormone bind globulin ( SHBG ) , dehydroepiandrosterone ( DHEA ) , dehydroepiandrosterone sulfate ( DHEAS ) , Measures estrogen action : plasma follicle stimulate hormone ( FSH ) , urinary estrogen metabolite . Measures systemic arachidonic acid-derived eicosanoids : urinary bicyclo-prostaglandin E2 ( PGEa ) , 2,3-dinor thromboxane B2 ( TXB2 ) . Measures reflect influence dietary fat fatty acid intake : plasma phospholipid , cholesterol ester , triglyceride free fatty acid composition .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Postmenopausal woman 45 70 year old , least one year since last menstrual period use hormone replacement therapy , BMI 19 29 willingness discontinue use overthecounter medication antiprostaglandin activity aspirin nonsteroidal antiinflammatory medication consumption `` Typical `` American diet unusual dietary practice compliance strict vegetarian diet willingness comply demand experimental protocol . Smoking Known disease process , 3 ) Use prescription medication , include hormone replacement therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>sex hormone</keyword>
	<keyword>urinary sex hormone metabolite</keyword>
</DOC>